Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Stroud

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|December 30, 2011
In vivo bio-imaging using chlorotoxin-based conjugatesMark R Stroud, Stacey J Hansen, James M Olson
Glycobiology|September 24, 2002
A highly conserved His-His motif present in alpha1-->3/4fucosyltransferases is required for optimal activity and functions in acceptor bindingAnne L Sherwood, David A Upchurch, Mark R Stroud, et al.
Journal of Medicinal Chemistry|January 8, 2011
Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapyMuharrem Akcan, Mark R Stroud, Stacey J Hansen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|February 26, 2004
Universal red blood cells--enzymatic conversion of blood group A and B antigensMartin L Olsson, Cheryl A Hill, Humberto de la Vega, et al.
Cancer Research|October 17, 2015
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid TumorsJanean Fidel, Katie C Kennedy, William S Dernell, et al.
Cancer Research|July 20, 2007
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer fociMandana Veiseh, Patrik Gabikian, S-Bahram Bahrami, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|December 30, 2011
In vivo bio-imaging using chlorotoxin-based conjugatesMark R Stroud, Stacey J Hansen, James M Olson
Glycobiology|September 24, 2002
A highly conserved His-His motif present in alpha1-->3/4fucosyltransferases is required for optimal activity and functions in acceptor bindingAnne L Sherwood, David A Upchurch, Mark R Stroud, et al.
Journal of Medicinal Chemistry|January 8, 2011
Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapyMuharrem Akcan, Mark R Stroud, Stacey J Hansen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|February 26, 2004
Universal red blood cells--enzymatic conversion of blood group A and B antigensMartin L Olsson, Cheryl A Hill, Humberto de la Vega, et al.
Cancer Research|October 17, 2015
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid TumorsJanean Fidel, Katie C Kennedy, William S Dernell, et al.
Cancer Research|July 20, 2007
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer fociMandana Veiseh, Patrik Gabikian, S-Bahram Bahrami, et al.
Pageof 1